Disease Teams: Compromised of a multi-disciplinary group whose primary responsibility is to oversee care, research and disease outcomes for a given tumor type. While we all see a variety of GI cancers, the teams monitor and maintain the treatment pathways, the clinical research portfolio, the CME programs, tumor boards, and outcomes.

General Membership: An integral contributor to our efforts to integrate discoveries in molecular medicine and translational research with a patient-centered philosophy to transform the standard of care for patients with gastrointestinal cancers.